Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Advances in Dermatology: New Therapies and Insights
This week's episode covers groundbreaking research in hidradenitis suppurativa, alopecia areata, atopic dermatitis, and cutaneous lupus erythematosus, featuring new biologic therapies and classification systems.
Bibliography
1. Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
Authors: Kimball AB, Sawicki KT, Ackerman L, et al.
Journal: JAMA dermatology, 2026 May 1
PMID: 41848710
DOI: 10.1001/jamadermatol.2026.0155
2. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
Authors: Starace M, Rapparini L, Pampaloni F, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41855013
DOI: 10.1007/s40257-026-01022-5
3. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.
Authors: Kulthanan K, Bernstein JA, Rudenko M, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41843011
DOI: 10.1007/s40257-026-01015-4
4. Hidradenitis Suppurativa.
Authors: McCarthy S
Journal: Annual review of medicine, 2025 Jan
PMID: 39869430
DOI: 10.1146/annurev-med-051223-031234
5. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Authors: Thaçi D, Puig L, Motegi SI, et al.
Journal: Acta dermato-venereologica, 2026 May 21
PMID: 42163822
DOI: 10.2340/actadv.v106.adv-2025-0160
6. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
Authors: Bobos M
Journal: Italian journal of dermatology and venereology, 2021 Jun
PMID: 33982546
DOI: 10.23736/S2784-8671.21.06958-3
7. The growing epidemic of sexually transmitted infections in adolescents: a neglected population.
Authors: Shannon CL, Klausner JD
Journal: Current opinion in pediatrics, 2018 Feb
PMID: 29315111
DOI: 10.1097/MOP.0000000000000578
8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Authors: King B, Zhang X, Harcha WG, et al.
Journal: Lancet (London, England), 2023 May 6
PMID: 37062298
DOI: 10.1016/S0140-6736(23)00222-2
9. SERPINA12 in skin: molecular mechanisms and roles in adipocytes, psoriasis, and palmoplantar keratoderma.
Authors: Xiao Z, Wang F, Li R, et al.
Journal: Frontiers in immunology, 2026
PMID: 42125668
DOI: 10.3389/fimmu.2026.1812302
10. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Authors: Niebel D, de Vos L, Fetter T, et al.
Journal: American journal of clinical dermatology, 2023 Jul
PMID: 37140884
DOI: 10.1007/s40257-023-00774-8
Authors: Kimball AB, Sawicki KT, Ackerman L, et al.
Journal: JAMA dermatology, 2026 May 1
PMID: 41848710
DOI: 10.1001/jamadermatol.2026.0155
2. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
Authors: Starace M, Rapparini L, Pampaloni F, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41855013
DOI: 10.1007/s40257-026-01022-5
3. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.
Authors: Kulthanan K, Bernstein JA, Rudenko M, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41843011
DOI: 10.1007/s40257-026-01015-4
4. Hidradenitis Suppurativa.
Authors: McCarthy S
Journal: Annual review of medicine, 2025 Jan
PMID: 39869430
DOI: 10.1146/annurev-med-051223-031234
5. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Authors: Thaçi D, Puig L, Motegi SI, et al.
Journal: Acta dermato-venereologica, 2026 May 21
PMID: 42163822
DOI: 10.2340/actadv.v106.adv-2025-0160
6. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
Authors: Bobos M
Journal: Italian journal of dermatology and venereology, 2021 Jun
PMID: 33982546
DOI: 10.23736/S2784-8671.21.06958-3
7. The growing epidemic of sexually transmitted infections in adolescents: a neglected population.
Authors: Shannon CL, Klausner JD
Journal: Current opinion in pediatrics, 2018 Feb
PMID: 29315111
DOI: 10.1097/MOP.0000000000000578
8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Authors: King B, Zhang X, Harcha WG, et al.
Journal: Lancet (London, England), 2023 May 6
PMID: 37062298
DOI: 10.1016/S0140-6736(23)00222-2
9. SERPINA12 in skin: molecular mechanisms and roles in adipocytes, psoriasis, and palmoplantar keratoderma.
Authors: Xiao Z, Wang F, Li R, et al.
Journal: Frontiers in immunology, 2026
PMID: 42125668
DOI: 10.3389/fimmu.2026.1812302
10. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Authors: Niebel D, de Vos L, Fetter T, et al.
Journal: American journal of clinical dermatology, 2023 Jul
PMID: 37140884
DOI: 10.1007/s40257-023-00774-8
